Discontinuation Rate Due to Intolerable Side Effects Semaglutide (2.4 mg): Overall discontinuation rate caused by adverse events: 2%4% Retatrutide (12 mg): Discontinuation rate: 7.7%13.5%Higher dropout rates for retatrutide are mainly driven by intractable nausea and vomiting at the maximum 12 mg dose
The 28-day billing cycle and limited lifestyle coaching are the platforms most documented friction points
But, some studies suggest taking it with other amino acids may create competition for absorption
According to the FDA prescribing information for both medications, frequent urination is not listed among the common adverse reactions observed in clinical trials
Chen B, Yu X, Horvath-Diano C, Ortuno MJ, Tschop MH, Jastreboff AM, et al
Increased energy, better recovery, and improved mood develop over the first one to two months